Machine learning driven drug repurposing strategy for identification of potential RET inhibitors against non-small cell lung cancer.

Med Oncol · 2022 · PMC9769489 · PMID 36542155

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Finally, the RFECV strategy was implemented to identify highly significant and relevant features.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.